Physician profile
Saima Khan
NPI 1881890416
$11,188.85
in general payments reported to CMS, 2019-2025
64 companies · $1,663 in 2025
The $1,663 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,472 · 2020: $1,461 · 2021: $1,538 · 2022: $1,504 · 2023: $1,728 · 2024: $1,823 · 2025: $1,663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,142 · Education: $71.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,141.88 |
| Education | $71.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,175.66 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $973.46 | 2019-2025 | Jardiance, Mounjaro, Trulicity |
| Corcept Therapeutics | $838.73 | 2019-2025 | Korlym |
| Amgen INC. | $712.55 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $533.08 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $492.68 | 2019-2023 | Lokelma, Farxiga |
| Dexcom, INC. | $479.37 | 2019-2025 | Dexcom G6 Transmitter |
| Amneal Pharmaceuticals LLC | $407.06 | 2019-2025 | Unithroid |
| Mannkind Corporation | $401.02 | 2019-2025 | Afrezza |
| Sanofi-Aventis U.S. LLC | $393.38 | 2019-2025 | |
| Abbott Laboratories | $387.07 | 2019-2025 | Freestyle Libre |
| Insulet Corporation | $333.98 | 2019-2025 | Omnipod |
| Antares Pharma, INC. | $256.39 | 2019-2025 | Xyosted |
| Tandem Diabetes Care, INC. | $246.00 | 2020-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $243.37 | 2020-2025 | Gvoke Hypopen, Recorlev |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $241.98 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $225.30 | 2021-2025 | |
| Amarin Pharma, INC. | $201.74 | 2019-2023 | |
| Recordati_rare_diseases_inc. | $193.73 | 2023-2025 | Isturisa, Signifor Lar |
| Merck Sharp & Dohme LLC | $173.98 | 2019-2021 | |
| Abbvie INC. | $162.96 | 2019-2024 | |
| Astellas Pharma US INC | $150.37 | 2024-2025 | Veozah |
| Radius Health, INC. | $130.81 | 2019-2025 | Tymlos |
| Currax Pharmaceuticals LLC | $130.53 | 2020-2025 | Contrave |
| Cequr Corporation | $114.36 | 2022-2025 | Cequr Simplicity |
| Alexion Pharmaceuticals, INC. | $104.17 | 2020-2025 | Strensiq |
| Ibsa Pharma INC. | $100.47 | 2019-2025 | Tirosint, Licart, Tirosint |
| Horizon Therapeutics Plc | $93.19 | 2020-2022 | |
| Medtronic, INC. | $80.92 | 2022-2025 | Minimed 780g |
| Acella Pharmaceuticals, LLC | $75.61 | 2023-2025 | NP Thyroid 60 |
| Beta Bionics, INC. | $65.14 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Madrigal Pharmaceuticals | $61.21 | 2024-2025 | Rezdiffra, Resmetirom |
| Novartis Pharmaceuticals Corporation | $59.60 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $56.10 | 2019 | |
| Becton, Dickinson and Company | $53.39 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.67 | 2020-2021 | |
| Lifescan, INC. | $44.21 | 2019-2023 | |
| Esperion Therapeutics, INC. | $44.14 | 2022 | |
| Zealand Pharma US, INC. | $44.08 | 2021-2022 | |
| Shire North American Group INC | $41.46 | 2019 | |
| Strongbridge US INC. | $41.28 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $39.80 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $36.08 | 2025 | |
| Sequel Med Tech, LLC | $35.30 | 2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $34.29 | 2025 | Yorvipath |
| Tolmar, INC. | $34.00 | 2023-2024 | |
| Valeritas, INC. | $33.13 | 2019 | |
| Companion Medical, INC. | $33.10 | 2020 | |
| Medtronic Minimed, INC. | $33.06 | 2019 | |
| Intuity Medical INC | $31.91 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Embecta Corp. | $30.72 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Regeneron Healthcare Solutions, INC. | $28.85 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $27.46 | 2019-2022 | |
| Topcon Healthcare Solutions, INC. | $27.03 | 2020 | |
| Eisai INC. | $19.74 | 2025 | |
| Soleno Therapeutics, INC. | $17.00 | 2025 | Vykat Xr |
| Kyowa Kirin, INC. | $17.00 | 2023 | Crysvita |
| Vivus LLC | $15.99 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.00 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $14.99 | 2019 | |
| Acerus Pharmaceuticals Corporation | $14.39 | 2021 | |
| Sanofi Pasteur INC. | $13.85 | 2019 | |
| Clarus Therapeutics INC. | $13.37 | 2021 | |
| Aytu Biopharma, INC. | $12.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saima Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.